TRANSLATIONAL PAIN RESEARCH
A CULTURED SPINAL CORD NEURON. NUCLEAR (BLUE), CYTOSKELETON (RED) AND GLYCINE RECEPTOR (GREEN) INMUNOSTAININGS ARE SHOWN. (CREDIT. NEUROPHARMACOLOGY LAB, UDEC)
PATCH-CLAMP RECORDING SETUP AND ACTIVATION OF LIGHT-SENSITIVE PROTEINS USING 470 nm ILLUMINATION
We are excited to announce the first edition of the Latin American Pain School (LAPS)!!!!
LAPS 2024 will be a two day theoretical and practical course held at the Pontificia Universidad Católica de Chile (PUC) in Santiago, Chile.
LAPS will focus on basic science and clinical topics related to acute and chronic pain, with an interdisciplinary perspective and a distinct research orientation.
LAPS is aimed at young scientists at the PhD or postdoctoral level (or equivalent) in all fields of pain science and pain medicine.
More information at: https://minuspain.cl/1st-latin-american-pain-school/
Link for application: LAPS application
CHECK OUT THE FEATURED PAPER OF THE WEEK
- 1st Latin American Pain School
- MAY 12: INTERNATIONAL DAY OF FIBROMYALGIA
- DRA. VIVIANA PÉREZ JOINS TO THE MINUSPAIN TEAM AS POSTDOCTORAL RESEARCH
- MARGARITA CALVO’S RECOMMENDED FOR QUÉ PASA MAGAZINE
- RESEARCH CARRIED OUT BY CHILEAN SCIENTISTS ACHIEVED IMPORTANT PROGRESS IN THE FIGHT AGAINST GASTRIC CANCER
- FOR THE OPTION TO NOT FEEL PAIN
- WHEN PAIN IS CHRONIC AND DISABLING: RESEARCHERS CREATE MINUSPAIN, THE FIRST SCIENTIFIC CENTER IN THE COUNTRY TO STUDY THIS ISSUE
- RESEARCHERS FROM THE FACULTY OF CHEMISTRY AND BIOLOGY WILL BE PART OF TWO OF THE NINE MILLENNIUM NUCLEUS
- MINUSPAIN: THE TRANSLATIONAL SCIENTIFIC ALLIANCE THAT GATHERS FIVE UNIVERSITIES IN THE COUNTRY TO FACE THE PROBLEM OF CHRONIC PAIN
- DIRECTOR OF MINUSPAIN SPEAKS AT AN INTERNATIONAL MEETING ON THE USE OF METFORMIN TO PREVENT NEUROPATHIC PAIN IN ONCOLOGICAL PATIENTS
- FIGHTING CHRONIC PAIN: THE ACADEMIC CRUSADE TO CREATE NEW THERAPIES
- MINUSPAIN: THE SCIENTIFIC ALLIANCE TO FACE THE PROBLEM OF CHRONIC PAIN
- MINUSPAIN PROMOTES SCIENTIFIC AND CLINICAL KNOWLEDGE DISSEMINATION PROGRAM FOR PEOPLE WITH FIBROMYALGIA
5 Principal Investigators, 2 Adjunct Investigators, 2 International Senior Members, 2 Junior Investigators
PUBLICATIONS since 2021
MILLENNIUM NUCLEUS FOR THE STUDY OF PAIN
We are a scientific consortium dedicated to investigate in translational neuroscience of pain. We aim at training advanced human capital in scientific and clinical area.
Our Millennium Nucleus MiNuSPain includes five research laboratories whose competences range from cutting-edge biomedical research to clinical studies. MiNusPain collaborations are reflected in associative projects, publications, international conferences and co-supervision of trainees.
Our work has a translational approach from the bedside to the bench and back, a concept that illustrates the path along which our lines of research progress collaboratively, ranging from biomedical science to patients. We are focused on investigating key molecular determinants involved in neuropathic pain. In particular, we will focus on the study of cellular and molecular mechanisms in preclinical and clinical models.
Photomicroscopy of a skin sample showing C fibres crossing toward the epidermis (PGP9.5 in red, DAPI in blue)
WHAT IS NEUROPHATIC PAIN?
It is defined as pain caused by an illness that affects the somatosensory nervous system.